Synthomer Share Discussion Threads

[philanderer] 27/10/2020 00:11

Synthomer PLC (LON:SYNT) was upgraded to ‘overweight217; from ‘neutral’; by JP Morgan after analysts looked at the company’s exposure to the gloves market. The polymer, sealant and chemicals specialist sells nitrile latex for nitrile gloves, a business which accounted for around 20% of 2019 group earnings. The main manufacturer in the sector, Top Glove, recently indicated that their lead time for nitrile gloves has extended significantly to 660 days compared to the average pre-pandemic lead time of 30-40 days. The US investment bank said gloves demand will moderate as COVID-19 vaccines become widely available, which may not be until the second half of 2021 or 2022, though it is also possible that the greater focus on hygiene might result in structurally higher gloves demand in the future. “We believe that both the magnitude and the duration of this upside is likely to be better than the market assumes,” analysts noted, while raising the target price to 450p. “There is a potential of further significant upside as we have significantly discounted the potential tailwind that we calculate from the substantial step-up seen in nitrile prices/spreads due to tight supply.” proactiveinvestors.co.uk/

[philanderer] 26/10/2020 14:15

Indeed it has ;-) Synthomer, up 2.5%. JPMorgan raised the speciality chemicals firm to Overweight from Neutral...tp 450p

[deadly] 26/10/2020 09:15

up 5% so far today. Tipped somewhere?

[philanderer] 21/10/2020 09:35

xd tomorrow morning for the 3p dividend

[james dean] 21/10/2020 09:30

philanderer Thanks.

[philanderer] 21/10/2020 09:17

JEFFERIES RAISES SYNTHOMER PRICE TARGET TO 440 (370) PENCE - 'BUY' MORGAN STANLEY RAISES SYNTHOMER TARGET TO 380 (350) PENCE - 'EQUAL-WEIGHT'

[philanderer] 19/10/2020 09:08

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 430 (370) PENCE - 'BUY'

[philanderer] 14/10/2020 17:29

As of last night.. 7th oct UBS neutral tp 325p 23rd sept Credit Suisse outperform tp 380p 18th sept HSBC buy tp 400p 17th aug Berenberg buy tp 370p 12th aug Barclays overweight tp 330p 6th aug ++++ trading/interims +++++

[sphere25] 14/10/2020 13:34

Very impressive performance: EBITDA: £232M 2.0x net debt to EBITDA by December 2020. Market cap @ 394: £1,670M Those multiples don't look excessive. I think this could end up significantly higher from these levels. Further upgrades to come? Looks a buy the dip play DBAM DYOR

[james dean] 14/10/2020 08:04

Pleasing update.

[deadly] 14/10/2020 07:55

Wow, that is a great update, and flying well below the radar.

[robow] 14/10/2020 07:23

FY2020 EBITDA guidance raised 10%, interim dividend reinstated and pro forma leverage expected to reduce to circa 2.0x EBITDA by end of 2020

[philanderer] 13/10/2020 13:20

Two days in a row !

[philanderer] 07/10/2020 10:37

UBS RAISES SYNTHOMER PRICE TARGET TO 325 (305) PENCE - 'NEUTRAL'

[philanderer] 24/9/2020 12:52

.. and fell away today,

[philanderer] 23/9/2020 16:56

That wooshed up this afternoon, almost 600k traded.

[philanderer] 23/9/2020 12:50

They're all at it :-) CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 380 (317) PENCE - 'OUTPERFORM'

[james dean] 18/9/2020 16:17

She certainly is. Thanks.

[philanderer] 18/9/2020 09:26

And even happier today ;-) HSBC RAISES SYNTHOMER PRICE TARGET TO 400 (350) PENCE - 'BUY'

[james dean] 17/8/2020 16:40

The wife will be pleased. 😀

[philanderer] 17/8/2020 08:54

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 370 (330) PENCE - 'BUY'

[philanderer] 13/8/2020 11:00

UBS today reaffirms its neutral investment rating on Synthomer (LON:SYNT) and raised its price target to 305p (from 285p).

[philanderer] 12/8/2020 10:12

BARCLAYS RAISES SYNTHOMER PRICE TARGET TO 330 (320) PENCE - 'OVERWEIGHT'

[philanderer] 07/8/2020 18:13

Almost got it back.